Starting on:
Mar 10, 2026
Ending on:
Mar 10, 2026
Moderator(s):
Zoom ID: 856 8057 8215
Max Credits:
3 Points
Provider:
Kenya Psychiatrists Association
Claim Points
Mar 10, 2026
Ending on:
Mar 10, 2026
Moderator(s):
Dr.
Rajab Saddam
Consultant Psychiatrists
Venue: Consultant Psychiatrists
Zoom ID: 856 8057 8215
Max Credits:
3 Points
Provider:
Kenya Psychiatrists Association
Claim Points
Beyond “Atypical”: Where Amisulpride Fits in Modern Schizophrenia Care
Starting on:
Mar 10, 2026
Mar 10, 2026
Ending on:
Mar 10, 2026
Mar 10, 2026
Venue:
Zoom ID: 856 8057 8215
Zoom ID: 856 8057 8215
Description
This webinar will explore the pharmacological characteristics, clinical efficacy, and therapeutic role of amisulpride in the contemporary management of schizophrenia. It will examine its distinctive dopamine receptor selectivity, clinical applications, and comparative benefits and limitations within the broader landscape of antipsychotic treatment. Emphasis will be placed on evidence-based prescribing, individualized treatment selection, safety monitoring, and optimizing functional outcomes and quality of life for individuals living with schizophrenia.
Objectives
By the end of the webinar, participants should be able to:
1. Understand the pharmacological profile and mechanism of action of amisulpride, including its selective dopamine D2/D3 receptor antagonism.
2. Evaluate the clinical efficacy of amisulpride in managing schizophrenia, including its role in addressing positive and negative symptoms.
3. Compare the efficacy, tolerability, and safety profile of amisulpride with other first- and second-generation antipsychotic medications.
4. Identify important clinical considerations when prescribing amisulpride, including hyperprolactinaemia, QT prolongation, renal function, and appropriate patient monitoring.
5. Apply evidence-based, patient-centred treatment strategies to determine the appropriate place of amisulpride in individualized schizophrenia management, with the aim of improving treatment adherence, functional recovery, and long-term patient outcomes.
Presenters
-
Dr.
Fredrick Owiti
Consultant Psychiatrist